论文部分内容阅读
将重磅炸弹药物作为保持增长的唯一出路是眼光短浅的做法。制药公司正在逐渐转向开发针对较小患者群的药物。
Using blockbuster drugs as the only way to sustain growth is short-sighted. Pharmaceutical companies are turning to developing drugs for smaller groups of patients.